Total amount raised
$348.3 Million
Latest funding date
11/1/2024
Location
Oura has successfully raised significant funding over multiple rounds, with notable investors such as Dexcom and Fidelity participating. The company is dedicated to developing smart rings that offer comprehensive health monitoring, including fitness, stress management, and sleep tracking.
Keep reading to explore the intricacies of Oura's fundraising journey and the investors backing this innovative platform.
What Is Oura?
Oura, founded in 2013 by Markku Koskela and Petteri Lahtela, is a health and wellness technology company based in Oulu, Finland. The company specializes in developing wearable rings that monitor sleep, stress, fitness, and overall health metrics.
Operating in the health care, mobile apps, and wearables industries, Oura has grown to employ between 251 and 500 people. The Oura Ring, their flagship product, is designed for all-day wear and provides users with detailed health insights through an accompanying app.
How Much Funding Has Oura Raised?
- Seed Round
- Amount Raised: $2.3M
- Date: November 2015
- Lead Investors: Lifeline Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop the initial prototype and launch the first version of the Oura Ring.
- Series A
- Amount Raised: $6M
- Date: September 2016
- Lead Investors: Harpreet Rai, Jaan Tallinn
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale production and expand market reach.
- Series A
- Amount Raised: $6M
- Date: April 2018
- Lead Investors: Bold Capital Partners, Tesi
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To enhance product features and improve the accompanying app.
- Series A
- Amount Raised: $6M
- Date: October 2018
- Lead Investors: DFO Management
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To further develop the technology and expand the team.
- Series B
- Amount Raised: $28M
- Date: March 2020
- Lead Investors: Forerunner, Gradient
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To accelerate growth and enter new markets.
- Series C
- Amount Raised: $100M
- Date: May 2021
- Lead Investors: Elysian Park Ventures, TCG
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and enhance product offerings.
- Series D
- Amount Raised: $200M
- Date: November 2024
- Lead Investors: Dexcom, Fidelity
- Valuation at Round: $5B
- Motivation Behind the Round: To integrate Dexcom's glucose data with Oura's health metrics.
Total Amount Raised: $348.3M. Current Valuation: $5B.
Key Investors
- Dexcom
- Details: Dexcom is a leading company in glucose monitoring technology. They invested $75M in Oura during the Series D round.
- Investment Focus Areas: Glucose monitoring, health metrics integration
- Notable Investments: Oura
- Fidelity
- Details: Fidelity is a multinational financial services corporation known for its investment management and brokerage services. They participated in Oura's Series D round.
- Investment Focus Areas: Financial services, technology, healthcare
- Notable Investments: Not publicly disclosed
- Elysian Park Ventures
- Details: Elysian Park Ventures is the private investment arm of the Los Angeles Dodgers ownership group. They invested in Oura during the Series C round.
- Investment Focus Areas: Sports, technology, health and wellness
- Notable Investments: Not publicly disclosed
- TCG
- Details: TCG, also known as The Chernin Group, is an investment firm that focuses on media, technology, and consumer brands. They were a key investor in Oura's Series C round.
- Investment Focus Areas: Media, technology, consumer brands
- Notable Investments: Not publicly disclosed
- Forerunner
- Details: Forerunner is a venture capital firm that invests in early-stage companies. They participated in Oura's Series B round.
- Investment Focus Areas: Consumer, retail, technology
- Notable Investments: Not publicly disclosed
What's Next for Oura?
Oura's future looks promising with significant opportunities on the horizon. The integration with Dexcom's glucose monitoring data could revolutionize health tracking, positioning Oura as a leader in the noninvasive glucose monitoring market. With an expected $500 million in sales next year, the company is poised for substantial growth.
Given its strong market position and recent $75 million Series D funding, Oura is well-placed to attract further investment. However, the company will need to navigate challenges such as competition from major players like Apple and ensuring the successful integration of new technologies.
Use Clay to Get Funding Data
Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like Oura and gather other critical business insights. Sign up for free and start making data-driven decisions today.
